Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemoradiation +/- Induction XELOX for Rectal Cancer with Liver Metastases
NCT01643070Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Jan 2010
- Primary completion
- Sep 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in rectal cancer, colorectal cancer (CRC), sponsored by Asan Medical Center. Started Jan 2010; status: completed.
02
Drugs
capecitabineoxaliplatin
03
Conditions
rectal cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01643070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01643070.